Support: 888-992-3836 Home NewsWire Subscriptions
InvestorsHub Logo
Login/Register
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ
  6. Nautilus Biotechnology Inc (NAUT)

  7. Nautilus Biotechnology Inc (NAUT) Financials

NAUT

Nautilus Biotechnology Inc

2.84
0.21 (7.98%)
Upgrade to Real-Time

Nautilus Biotechnology Inc. (NAUT) Fundamentals
Nautilus Biotechnology Inc is a development stage life sciences company creating a platform technology for quantifying and unlocking the complexity of the human proteome. It has built a prototype of a single-molecule instrument, Proteomic Analysis System.
SHARE INFORMATION
Market Cap$ 328,398,611
Shares Outstanding124,723,525
Float56,792,453
Percent Float45.48%
Short Interest0.00
Short Percent Float0.0%
Short Interest Ratio0.00
Short Interest Date-
Latest Fiscal Dividend Per Share$ 0.00
Latest Fiscal Revenue$ 0
Latest Fiscal EPS$ -0.46
Latest Fiscal Date2022-12-31
DIVIDENDS
Dividend (3 Years)$ 0.00
Dividend (5 Years)$ 0.00
Ex Dividend Date-
Dividend Rate$ 0.00
Dividend Yield0.0%
Payment Cash-
HOLDERS
Institutions193
Institutional Holdings Date2023-03-31
Institutional Bought Previous 3 Months642,603
Institutional Holdings Percent59.5%
Institutional Sold Previous 3 Months1,388,246
Insider Holdings Date2023-03-31
Insider Bought Previous 3 Months1,890,000
Insider Holdings Percent25.0
Insider Sold Previous 3 Months-
Insider Shares Owned31,182,705
TRADING INFO
52 Week High$ 3.98
52 Week Low$ 1.50
52 Week High Change$ -23.77
21 Day Moving Average$ 2.4502
21 Day Extended Moving Average$ 2.4943
50 Day Moving Average$ 2.5367
50 Day Extended Moving Average$ 2.4494
200 Day Moving Average$ 2.1653
200 Day Extended Moving Average$ 2.5217
10 Day Average Volume65,522
20 Day Average Volume58,681
30 Day Average Volume59,688
50 Day Average Volume96,285
Alpha-0.047209
Beta0.9602
Standard Deviation0.161603
R20.113796
7 Day Price Change$ 0.28
7 Day Percent Change11.91%
21 Day Price Change$ 0.33
21 Day Percent Change14.35%
30 Day Price Change$ 0.16
30 Day Percent Change6.48%
Month to Date Price Change$ 0.05
Month to Date Percent Change1.94%
Quarter to Date Price Change$ -0.14
Quarter to Date Percent Change-5.05%
180 Day Price Change$ 0.85
180 Day Percent Change47.75%
200 Day Price Change$ 0.55
200 Day Percent Change26.44%
Year to Date Price Change$ 0.83
Year to Date Percent Change46.11%

Nautilus Biotechnology Inc. (NAUT) Key Ratios

PROFITABILITY
EBIT Margin-29.1%
EBITDA Margin-26.0%
Pre-Tax Profit Margin-3.4%
Profit Margin Count-0.11%
Gross Margin18.4%
Profit Margin TOT0.0%
INCOME STATEMENTS
Revenue$ 0
Revenue Per Share$ 0.00
Revenue (3 Years)$ 3.01
Revenue (5 Years)$ -3.60
FINANCIAL STRENGTH
Price to Tangible Book0.50
Total Debt To Equity1.00
Int Coverage0.00
Current Ratio2.50
Leverage Ratio2.70
Quick Ratio1.00
Long Term Debt To Capital0.48
VALUATION MEASURES
PE Ratio0.00
Enterprise Value$ 104,420,956
Price to Sales0.12
Price to Free Cash7.60
PE High Last 5 Years116.10
Price To Book0.40
Price To Cash Flow0.00
PE Low Last 5 Years-17.20
Price to Tangible Book0.50
MANAGEMENT EFFECTIVENESS
Receivables Turnover5.00
Invoice Turnover2.70
Assets Turnover1.10
Return Assets-34.68
Return on Equity-77.88
Return on Capital-46.77

Nautilus Biotechnology Inc. (NAUT) Profile

PROFILE INFO
Issue TypeCS
SEC Type-
AuditorGRANT THORNTON LLP
CEOSujal M. Patel
Employees124
Last Audit-
CIK0001808805
IndustryHotels, Lodging & Leisure
SectorConsumer Discretionary
NAICSAnalytical Laboratory Instrument Manufacturing(334516)
CONTACT INFO
Address2701 Eastlake Avenue East,Suite 202
Suite 202
Seattle, WA 98102
Websitehttps://www.nautilus.bio
Facsimile-
Telephone+1 206 333-2001
Email-


Your Recent History
NASDAQ
NAUT
Nautilus B..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

Log in to InvestorsHub
Register Now

NYSE, AMEX, and ASX quotes are delayed by at least 20 minutes.
All other quotes are delayed by at least 15 minutes unless otherwise stated.